Medical workers prepare to inject into volunteers (Photo: VNA)Hanoi (VNA) – Three volunteers
getting the first shot of the 25mcg dose of Nanocovax, the first Vietnamese
to be tested on humans, last December received the second on
January 14.
The three, comprising one male and two females
aged between 20 and 25, are among the first 20 volunteers given the vaccine on
December 17, 2020.
Prof. Do Quyet, Director of the Hanoi-based
, said the second shot comes 28 days after
the first one.
As volunteers haven’t shown abnormal symptoms
after getting the first injection, the 25mcg, 50mcg, and 75mcg doses of
Nanocovax have been tested on remaining groups of volunteers safely.
So far, all volunteers have been in stable
health condition. Some felt pain at the injection site or mild fever, but the
symptoms disappeared after 24 hours, Quyet noted.
Assoc. Prof. Chu Van Men, Director of the
university’s clinical trial centre, said 50 percent of the first phase of human
trials has completed.
The university has received more than 500
applications for Nanocovax trials, but only 51 are eligible for joining the
first phase of testing due to strict selection criteria.
Phase I, with the doses of 25mcg, 50mcg, and
75mcg injected, aims to evaluate the vaccine’s safety. Phase II is set to
conduct testing on 560 people and begin in February to assess the vaccine’s
effectiveness. Meanwhile, the third phase will need at least 1,500 – 3,000
volunteers, including those in other countries.
If everything goes as planned, the first two
phases will finish in February and be followed by the third one when half of
Phase II is completed.
Vietnam is one of the 40 countries that have
conducted human trials of a vaccine.
Nanocovax is developed by the Nanogen
Pharmaceutical Biotechnology JSC, basing on recombinant protein technology.
The country also has several other COVID-19
candidate vaccines being developed, by the Institute of Vaccines and Medical
Biologicals (IVAC), the Company for Vaccine and Biological Production No.1
(VABIOTECH), and the Centre for Research and Production of Vaccines and
Biologicals (POLYVAC)./.
Source: VietnamPlus
